1 Nov – Recently, the former member of the disbanded group A'st1, Sung In-kyu revealed that he has been diagnosed with thymus cancer, according to allkpop. On 31 October, the singer posted on his mini ...

MIT researchers have developed an experimental mRNA-based therapy that restored key immune functions lost with age in mice.

There's a small fatty gland that sits behind your sternum and is often said to be 'useless' in adulthood. A retrospective ...

UCLA researchers have created a new system to produce human T cells, the white blood cells that fight against disease-causing intruders in the body. The system could be utilized to engineer T cells to ...

Dear Doctor Roach: I have recently learned that my sibling, age 70, has rare cancer of the thymus. She will be getting chemotherapy and perhaps radiation treatment. I have heard of immunotherapy. Is ...

DUBLIN--(BUSINESS WIRE)--The "Thymus Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering. The report ...

Scientists have mapped the thymus, a gland in the chest that makes disease-fighting white blood cells, across the human life span. This “cell atlas” could help researchers understand how thymus cells ...

Researchers at MIT have unveiled a way to coax an aging immune system into acting young again, using the same kind of mRNA ...

Please provide your email address to receive an email when new articles are posted on . Current treatments for thymic cancers did not significantly increase risk for cardiovascular disease, according ...

A new preclinical model for thymic cancer has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation. The model may help speed the development of ...

The combination of carboplatin and paclitaxel compared favorably with standard anthracycline-based chemotherapy in the treatment of thymic carcinoma, according to results of a multicenter phase 2 ...

Sunitinib (Sutent, Pfizer) has shown activity in the second-line treatment of thymic cancer, a disease where numerous other agents have been tested and failed. The results come from the first clinical ...